| pubmed-article:2112423 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2112423 | lifeskim:mentions | umls-concept:C0029925 | lld:lifeskim |
| pubmed-article:2112423 | lifeskim:mentions | umls-concept:C1518174 | lld:lifeskim |
| pubmed-article:2112423 | lifeskim:mentions | umls-concept:C0003339 | lld:lifeskim |
| pubmed-article:2112423 | lifeskim:mentions | umls-concept:C0040690 | lld:lifeskim |
| pubmed-article:2112423 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:2112423 | lifeskim:mentions | umls-concept:C0851285 | lld:lifeskim |
| pubmed-article:2112423 | lifeskim:mentions | umls-concept:C1514485 | lld:lifeskim |
| pubmed-article:2112423 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:2112423 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:2112423 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2112423 | pubmed:dateCreated | 1990-7-13 | lld:pubmed |
| pubmed-article:2112423 | pubmed:abstractText | Transforming growth factor-beta (TGF-beta) is a multifunctional peptide regulating several processes in ovarian cells. The growth of ovarian carcinoma cell lines (OVCAR-3, HTB-77, 2780 and CRL-1572) was reduced by TGF-beta in a dose related manner. The antiproliferative activity was not improved by combination with other biological response modifiers. Treatment with TGF-beta augmented the expression of interferon-gamma induced class I and II antigens of the major histocompatibility complex. The presentation of another antigen namely the tumor marker CA-125 on the cell surface was markedly reduced by TGF-beta. | lld:pubmed |
| pubmed-article:2112423 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2112423 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2112423 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2112423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2112423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2112423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2112423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2112423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2112423 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2112423 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:2112423 | pubmed:issn | 0304-3835 | lld:pubmed |
| pubmed-article:2112423 | pubmed:author | pubmed-author:LaneVV | lld:pubmed |
| pubmed-article:2112423 | pubmed:author | pubmed-author:DaxenbichlerG... | lld:pubmed |
| pubmed-article:2112423 | pubmed:author | pubmed-author:MayerII | lld:pubmed |
| pubmed-article:2112423 | pubmed:author | pubmed-author:MartiBB | lld:pubmed |
| pubmed-article:2112423 | pubmed:author | pubmed-author:KozaAA | lld:pubmed |
| pubmed-article:2112423 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2112423 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:2112423 | pubmed:volume | 51 | lld:pubmed |
| pubmed-article:2112423 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2112423 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2112423 | pubmed:pagination | 221-5 | lld:pubmed |
| pubmed-article:2112423 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:meshHeading | pubmed-meshheading:2112423-... | lld:pubmed |
| pubmed-article:2112423 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2112423 | pubmed:articleTitle | Transforming growth factor-beta and ovarian carcinoma cells: regulation of proliferation and surface antigen expression. | lld:pubmed |
| pubmed-article:2112423 | pubmed:affiliation | Department of Obstetrics and Gynecology, Innsbruck University Clinic, Austria. | lld:pubmed |
| pubmed-article:2112423 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2112423 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2112423 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2112423 | lld:pubmed |
